TY - JOUR
T1 - Patient-reported outcomes in the setting of a randomized control trial on the efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome
AU - Ramírez-García, Inés
AU - Kauffmann, Stéphanie
AU - Blanco-Ratto, Laia
AU - Carralero-Martínez, Andrea
AU - Sánchez, Emília
N1 - Funding Information:
This study was supported in part by a grant (V Basic Research Grant in Physiotherapy) from the Acadèmia de Ciències Mèdiques i de la Salut. Societat Catalano‐Balear de Fisioteràpia. Co‐funded by RAPbarcelona Physiotherapy Clinical Center. The authors would like to thank Blanquerna School of Health Sciences (Ramon Llull University); RAPbarcelona Physiotherapy Clinical Center and Instituto Médico Tecnológico Clinical Center, for helping in the data collection and analysis.
Funding Information:
This study was supported in part?by a grant (V Basic Research Grant in Physiotherapy) from the Acad?mia de Ci?ncies M?diques i de la Salut. Societat Catalano-Balear de Fisioter?pia. Co-funded by RAPbarcelona Physiotherapy Clinical Center. The authors would like to thank Blanquerna School of Health Sciences (Ramon Llull University); RAPbarcelona Physiotherapy Clinical Center and Instituto M?dico Tecnol?gico Clinical Center, for helping in the data collection and analysis.
Publisher Copyright:
© 2020 Wiley Periodicals LLC
PY - 2021/1
Y1 - 2021/1
N2 - Aim: To compare the efficacy of transcutaneous tibial nerve stimulation (TTNS) with percutaneous tibial nerve stimulation (PTNS) regarding patient-reported outcomes measures, specifically quality-of-life (QoL) improvement and patient's treatment benefit, on symptoms associated with overactive bladder (OAB). Methods: Patients with refractory OAB symptoms and detrusor overactivity were randomized to receive TTNS or PTNS for 12 weeks. Data from self-report OAB questionnaire short form (q-SF) and incontinence (I)-QoL questionnaires were collected pretreatment and at Weeks 6 and 12. Patients’ self-perceived benefits on symptoms (treatment benefit scale, TBS) were also gathered. Mean change in scores within and between groups were estimated. Results: Sixty-eight adult patients (67.6% women) were included in the intention to treat analysis. Of those, 61 completed all questionnaires and were analyzed as per protocol. Statistically significant improvements in OAB-q-SF and I-QoL between baseline and end-of-treatment scores were observed in both TTNS and PTNS groups (p <.001), being the differences much higher than the minimal important difference in both questionnaires. The scores of the OAB-q-SF scales (symptoms bother and health-related QoL) showed no statistically significant differences between the two groups. Similarly, the differences regarding the I-QoL questionnaire were statistically nonsignificant either (p =.607). When assessing the treatment benefit on symptoms, TBS responses between groups showed no statistical differences. Conclusion: A significant improvement of QoL was observed in both TTNS and PTNS groups. However, no patient-reported outcomes measures scores support a difference between the two groups. Therefore, these findings along with TTNS ease of application and less invasiveness may lead to an increased indication of this technique for OAB.
AB - Aim: To compare the efficacy of transcutaneous tibial nerve stimulation (TTNS) with percutaneous tibial nerve stimulation (PTNS) regarding patient-reported outcomes measures, specifically quality-of-life (QoL) improvement and patient's treatment benefit, on symptoms associated with overactive bladder (OAB). Methods: Patients with refractory OAB symptoms and detrusor overactivity were randomized to receive TTNS or PTNS for 12 weeks. Data from self-report OAB questionnaire short form (q-SF) and incontinence (I)-QoL questionnaires were collected pretreatment and at Weeks 6 and 12. Patients’ self-perceived benefits on symptoms (treatment benefit scale, TBS) were also gathered. Mean change in scores within and between groups were estimated. Results: Sixty-eight adult patients (67.6% women) were included in the intention to treat analysis. Of those, 61 completed all questionnaires and were analyzed as per protocol. Statistically significant improvements in OAB-q-SF and I-QoL between baseline and end-of-treatment scores were observed in both TTNS and PTNS groups (p <.001), being the differences much higher than the minimal important difference in both questionnaires. The scores of the OAB-q-SF scales (symptoms bother and health-related QoL) showed no statistically significant differences between the two groups. Similarly, the differences regarding the I-QoL questionnaire were statistically nonsignificant either (p =.607). When assessing the treatment benefit on symptoms, TBS responses between groups showed no statistical differences. Conclusion: A significant improvement of QoL was observed in both TTNS and PTNS groups. However, no patient-reported outcomes measures scores support a difference between the two groups. Therefore, these findings along with TTNS ease of application and less invasiveness may lead to an increased indication of this technique for OAB.
KW - OAB-q-SF
KW - PTNS
KW - overactive bladder
KW - quality of life
KW - transcutaneous tibial nerve stimulation
KW - treatment benefit scale
UR - http://www.scopus.com/inward/record.url?scp=85094204136&partnerID=8YFLogxK
U2 - 10.1002/nau.24554
DO - 10.1002/nau.24554
M3 - Article
C2 - 33118624
AN - SCOPUS:85094204136
SN - 0733-2467
VL - 40
SP - 295
EP - 302
JO - Neurourology and Urodynamics
JF - Neurourology and Urodynamics
IS - 1
ER -